Gene Query: MAVS

Dataset Description Geneva Score
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 58.69
CD95/Fas ligand mRNA is toxic to cells 51.3
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 42.49
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 29.13
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 28.76
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 28.62
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 28.34
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 28.34
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 28.2
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 27.86
ARS2 is a general suppressor of pervasive transcription [RNAseq] 26.8
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 25.79
RIG-I and MDA5 fRIP during KSHV lytic reactivation 25.57
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 24.04
Role of microRNAs in the interaction between Salmonella and the host cell 23.83
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 23.53
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 23.52
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 23.48
Differential expression of genes in AD169-infected MRC5. 22.99
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 22.76
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 22.54
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 22.36
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 21.81
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 21.77
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 21.77
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 21.34
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 21.34
ETV7 and interferon response 21.34
IDH3a KO RNA-seq 21.03
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 20.29
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 20.29
Transcriptome of U251 cells overexpression complement component 7 20.16
Gene Expression Profiling of SPOP Knocked Down Cell 20.02
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 19.82
Sensing self and nonself circular RNAs 19.39
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 19.24
Human HAP1 cells before and after nutrient deprivation 19.24
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 18.74
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 18.54
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 18.53
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 18.45
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 18.22
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 18.22
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 18.13
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 17.93
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 17.92
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 17.91
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 17.87
Transcriptome analysis of Zika infected neural stem cells 17.45
Zika infected neural stem cells 17.45
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 17.32
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 16.88
An RNA-centric dissection of host complexes controlling flavivirus infection 16.88
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 16.81
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 16.63
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 15.98
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 15.98
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 15.78
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 15.75
Lysine benzoylation is a novel histone mark 15.64
Lysine benzoylation is a novel histone mark [RNA-seq] 15.64
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 15.51
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 15.42
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 15.41
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 15.32
Role of XRN2 ribonucleolytic activity in RNA metabolism 15.3
Mitochondrial dsRNA triggers antiviral signalling in humans 15.28
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 15.25
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 15.25
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 15.25
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 15.12
Cell responses to dysregulated VZV-induced cell-cell fusion 14.85
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 14.75
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 14.47
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 14.47
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 14.41
Global response to chemotherapy-induced apoptosis 14.4
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 14.39
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 14.3
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 14.11
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 13.91
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 13.81
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 13.75
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 13.72
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 13.48
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 13.48
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 13.42
DART-seq: an antibody-free method for global m6A detection 13.37
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 13.34
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 13.08
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 13.02
hnRNP C is a key regulator of protein synthesis in mitosis 13.0
Effect of Influenza virus infection on lncRNA expression in A549 cells 12.86
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 12.82
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 12.82
RNA-seq of YB5 cells treated with Proscillaridin A 12.74
RNA-seq of tumor cells following angiopellosis extravasation 12.63
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 12.57
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 12.57
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 12.51
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 12.42
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 12.42
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 12.35
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 12.35
EWSR1 influences alternative splicing through direct and indirect mechanisms 12.35
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 12.3
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 12.28
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 12.28
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 12.26
MYC dependent mRNA translation shapes gene expression and cell biology 12.23
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 12.16
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 12.13
hTERT promotes cell adhesion and migration independent of telomerase activity 12.13
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 12.0
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 11.99
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 11.96
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 11.96
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 11.96
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 11.92
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 11.9
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 11.85
SETBP1-WT and SETBP1-G870S epigenetic landscapes 11.85
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 11.78
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 11.78
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 11.75
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 11.54
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 11.5
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 11.3
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 11.19
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 11.19
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 11.14
Direct Isolation and Characterization of Human Nephron Progenitors. 10.99
Effect of disulfiram treatment on pediatric high grade glioma 10.96
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 10.96
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 10.9
Regulation of highly expressed hCINAP on translatome 10.88
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 10.86
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 10.67
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 10.66
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 10.62
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 10.61
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 10.61
Identification of global regulators of T-helper cell lineage specification 10.61
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 10.58
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 10.55
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 10.51
RNA-seq analyses of human prostate cancer cells 10.45
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 10.43
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 10.41
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 10.41
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 10.41
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 10.39
Mechanistic Model-Guided Study of Embryonic Morphogenesis 10.37
RNA sequencing of mechanically strained NHEKs and control NHEKs 10.31
Integrating single-cell transcriptomic data across different conditions, technologies, and species 10.29
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 10.21
Differentially expressed genes post knock down of lincDUSP26 10.2
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 10.18
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 10.18
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 10.12
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 10.1
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 10.07
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 10.07
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 10.05
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 9.98
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 9.92
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 9.9
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 9.84
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 9.82
Transcriptomic profiling of human peripheral blood-derived mast cells 9.76
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 9.76
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 9.73
Intron retention induced by microsatellite expansions as a disease biomarker. 9.72
Single-Cell Genotyping of Transcriptomes 9.69
RNA-seq of Single-Cell Genotyping of Transcriptomes 9.69
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 9.69
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 9.67
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 9.66
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.57
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 9.56
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 9.5
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 9.5
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 9.48
Novel Targeting of Transcription and Metabolism in Glioblastoma 9.46
Identification of long noncoding RNAs regulated by p53 9.42
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 9.37
Tracking of dCas9-methyltransferase footprints 9.36
Expression level comparison under dividing and quiescent states in human primary fibroblasts 9.34
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 9.24
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 9.21
TCF7L1 knockdown in pancreatic cancer 9.19
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 9.17
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 9.17
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 9.17
Transcriptomic analysis of ERR alpha orphan nuclear receptor 9.15
Argonaute proteins couple chromatin silencing to alternative splicing 9.14
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 9.14
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 9.11
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 9.06
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 9.04
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 8.97
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 8.88
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 8.82
8.78
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 8.74
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.67
Gene expression in PANC1 cells treated with Rakicidin 8.66
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 8.64
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 8.62
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 8.59
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 8.52
Ribosomal footprinting of MDA-Parental and MDA-LM2 8.5
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 8.5
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 8.49
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 8.46
MicroRNA-125a-5p overexpression in human macrophages 8.38
mRNA expression in human DAOY cells 8.28
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 8.26
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 8.23
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 8.22
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 8.21
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.19
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 8.15
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 8.13
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 8.06
RNA-seq analyisis of PUM2 knockout cells 8.03
Exploring the RNA landscape of endothelial exosomes 7.98
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 7.93
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 7.9
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 7.83
Identifying the molecular mode of action of itraconazole in colorectal cancer 7.79
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 7.78
FBXW7 modulates stress response by post-translational modification of HSF1 7.78
DIGIT regulates endoderm differentiation of human embryonic stem cells 7.77
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 7.76
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 7.76
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 7.74
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 7.74
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 7.72
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 7.7
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 7.7
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 7.62
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 7.58
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 7.57
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 7.53
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.5
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 7.45
Transcriptome wide analysis of classically and alternatively activated macrophages 7.42
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 7.41
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 7.35
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  7.34
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 7.31
4sUDRB-seq: measuring transcription elongation and initiation genomewide 7.2
Effect of from Human Umbilical Vein Endothelial Cells 7.19
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 7.18
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 7.16
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.14
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.14
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 7.13
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 7.08
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 7.06
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 6.97
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 6.97
Comparative Analysis of Cas9 Activators Across Multiple Species 6.97
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 6.92
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 6.92
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 6.92
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 6.91
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 6.85
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 6.77
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 6.74
Differentiation enhances Zika virus infection in neuronal brain cells 6.7
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 6.7
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 6.69
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 6.68
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 6.66
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 6.66
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 6.66
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 6.65
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 6.61
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 6.55
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 6.46
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 6.44
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 6.44
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 6.37
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 6.37
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 6.37
Genome-wide identification of cancer-specific alternative splicing in circRNA 6.34
Single-cell analysis of human kidney organoids 6.34
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 6.29
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 6.27
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.26
RNA polymerase in pre-B-ALL cell lines 6.04
MARS Seq data from human cortical organoids 6.03
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 6.01
HEK293 TFAM Knockout Expression Study 5.94
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 5.94
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 5.9
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 5.87
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.81
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.81
Effect of BB608 on Gene Expression in HNSCC Cell Line 5.8
Searching for target genes of miR-508/509/506/514 in HCT116 cells 5.79
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.75
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 5.73
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 5.67
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 5.66
Capturing the Interactome of Newly Transcribed RNA 5.64
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.64
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 5.59
Expression profiling of MCF-7 cells with treatment of TCDD 5.59
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 5.57
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 5.57
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 5.51
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 5.51
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 5.51
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 5.46
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 5.43
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 5.4
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 5.4
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 5.32
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 5.3
Effects of rFVIIIFc on human macrophages 5.27
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.26
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 5.26
LINE-2 transposable elements are a source of functional human microRNAs and target sites 5.25
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 5.23
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.22
Transcriptomic analysis of LSD1 5.2
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.19
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 5.17
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 5.12
Gene expression changes after LOC550643 silencing 5.1
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 5.05
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 5.05
Effect of drugs on transcriptomic profiles 4.98
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 4.95
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 4.92
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 4.92
RNA Sequencing of Human iPS derived Cardiomyocytes 4.92
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 4.89
EGR1-controlled transcriptome of T HESCs 4.88
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.84
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 4.82
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 4.78
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 4.75
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 4.73
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 4.71
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 4.69
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.67
Gene expression profile of human placenta from T. Cruzi infected mothers 4.65
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 4.56
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 4.52
Evaluating pre-clinical models for studying NASH driven HCC. 4.5
RNA-seq of RKO cells with cTAZ KO or putback 4.45
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 4.42
Fibroblasts in cholesteatoma activate osteoclasts. 4.35
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 4.33
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 4.29
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.25
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.25
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.95
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 3.93
Impact on erythroid progenitor type on erythroid differntiation 3.93
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.91
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.86
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 3.82
Functional Haploid Human Oocytes Generated from Polar Body Genomes 3.82
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 3.77
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 3.77
Transcriptome analysis of peripheral blood monocytes 3.74
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.74
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.64
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.61
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.61
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.54
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 3.45
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 3.44
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.36
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.36
Widespread intronic polyadenylation diversifies immune cell transcriptomes 3.34
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 3.3
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 3.28
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 3.27
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 3.27
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.24
SNHG5 siRNA knock down in HCT116 cells 3.21
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 3.21
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 3.16
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 3.12
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 3.12
Trascriptome of thyroid cancer-induced macrophages 3.09
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.06
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.98
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.96
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.96
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.94
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.9
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.9
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.9
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 2.88
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 2.88
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 2.78
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.78
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 2.77
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.71
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.71
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 2.69
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 2.66
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.51
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 2.44
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 2.33
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 2.33
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.27
The bromodomain protein BRD4 regulates splicing during heat shock 2.2
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 2.18
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.12
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 2.07
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 2.07
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2.07
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.0
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.95
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.95
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.95
Exogenous rescue of KLHL9 in SF210 cell line 1.89
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.88
6mer seed toxicity in viral microRNAs 1.85
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.75
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.7
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.65
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 1.58
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 1.58
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.58
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.51
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 1.46
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 1.46
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.44
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 1.43
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.42
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.42
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.39
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.38
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.36
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.36
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.29
STX4 Over-Expression in Human islets 1.24
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 1.23
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.2
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.19
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 1.18
Recovery and analysis of nascent RNA 1.18
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 1.16
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 1.16
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.15
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.15
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.15
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.13
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.1
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.1
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.1
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 1.08
Transposon-based construction of strand-specific RNA-seq libraries 1.07
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.06
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.99
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.97
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.92
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.91
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.91
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 0.84
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 0.78
Deep RNA sequencing of the human placental transcriptome 0.75
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.74
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.74
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.74
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.67
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.67
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.65
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.56
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.56
RNA-seq of IL-4 stimulated human keratinocytes 0.55
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.55
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.52
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 0.52
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.49
Dilated cardiomyopathy vs Myocarditis 0.47
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.45
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.38
RNA-seq of primary patient AML samples 0.37
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.36
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.36
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.3
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.29
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.14
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.13
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.13
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.12
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.1
The pioneer factor CEBPA modulates vitamin D signaling 0.1
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 0.06
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation